C2N DIAGNOSTICS LLC has a total of 39 patent applications. It increased the IP activity by 800.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CANIMGUIDE THERAPEUTICS AB, NEURIMMUNE HOLDING AG and BIOGEN INT NEUROSCIENCE GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 2 | |
#6 | China | 2 | |
#7 | Israel | 2 | |
#8 | Singapore | 2 | |
#9 | Taiwan | 2 | |
#10 | Brazil | 1 | |
#11 | Chile | 1 | |
#12 | Costa Rica | 1 | |
#13 | Dominican Republic | 1 | |
#14 | Ecuador | 1 | |
#15 | Japan | 1 | |
#16 | Republic of Korea | 1 | |
#17 | Mexico | 1 | |
#18 | Peru | 1 | |
#19 | Philippines | 1 | |
#20 | Russian Federation | 1 | |
#21 | Ukraine | 1 | |
#22 | Uruguay | 1 | |
#23 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Jones Timothy D | 20 |
#2 | Carr Francis J | 20 |
#3 | West Tim | 20 |
#4 | Athwal Diljeet S | 19 |
#5 | Holgate Robert George Edward | 14 |
#6 | Tim West | 6 |
#7 | Meyer Matthew R | 5 |
#8 | Yarasheski Kevin E | 4 |
#9 | Diljeet S Athwal | 4 |
#10 | Francis J Carr | 4 |
Publication | Filing date | Title |
---|---|---|
US2018364260A1 | Methods for extracting and measuring concentrations of biomolecules in complex matrices without the need for immunocapture | |
CA3052971A1 | Methods for measuring concentrations of biomolecules in biofluids | |
US2020030445A1 | Stable formulations of humanized anti-tau antibody | |
TW201946931A | Humanized anti-TAU antibodies |